NUP214 in Acute Myeloid Leukemia.

Area of Science:

• Molecular Biology
• Hematology
• Oncology

Background:

• Nucleoporin 214 (NUP214) participates in nucleocytoplasmic transport and regulates gene expression, cell signaling, cell cycle, and apoptosis.
• NUP214 gene rearrangements are implicated in leukemic transformation in acute myeloid leukemia (AML).

Purpose of the Study:

• To review the functions of NUP214-related fusion genes and proteins in AML.
• To analyze molecular mechanisms, biological functions, and clinical characteristics associated with these AML variants.
• To evaluate the prognostic impact of NUP214 fusion genes in AML.

Main Methods:

• Literature review of studies on NUP214 fusion genes in AML.
• Analysis of molecular mechanisms and biological functions of fusion proteins.
• Review of clinical and pathological characteristics of AML patients with NUP214 fusions.

Main Results:

• The t(6;9) translocation yielding DEK-NUP214 fusion protein occurs in 1-2% of AML cases, associated with adverse prognosis.
• SET-NUP214, NUP214-ABL1, and NUP214-SQSTM1 fusions are less common, with SET-NUP214 showing biological similarities to DEK-NUP214.
• Prognostic impact of SET-NUP214 and other rare fusions remains largely unknown.

Conclusions:

• NUP214 fusions represent diverse molecular events in AML with varying clinical implications.
• Further research is needed to elucidate the prognostic significance of less common NUP214 fusion variants.
• Understanding these fusions is crucial for targeted therapies and improved AML patient outcomes.